Arkray: Innovation in Diabetes Diagnostics and Monitoring

Arkray has spent over 50 years developing advanced diagnostic and monitoring solutions for diabetes, making it one of the most established global leaders in this field. With a focus on blood glucose monitoring (SMBG), glycated hemoglobin (HbA1c) testing, urinalysis, and point-of-care (POC) diagnostics, the company plays a critical role in improving the management of diabetes for patients and healthcare providers worldwide.

Blood Glucose Monitoring (SMBG)

Managing diabetes effectively requires accurate, real-time glucose measurements. Arkray produces highly sensitive SMBG systems designed to provide fast, precise readings with minimal user error. These glucose monitors are built for both clinical and home use, ensuring that patients can track their blood sugar levels consistently. The technology behind Arkray’s SMBG devices prioritizes small blood sample requirements, rapid processing times, and reliable calibration methods, making them essential for people who need frequent testing.

HbA1c Testing

Unlike daily glucose testing, HbA1c measurement provides a broader picture of blood sugar control over several months. Arkray’s HbA1c analyzers allow healthcare professionals to assess average glucose levels over 8–12 weeks, helping to determine the effectiveness of treatment plans. This test is particularly important for early detection of prediabetes, adjusting insulin therapy, and preventing complications. By developing automated, high-precision HbA1c analyzers, Arkray enables faster and more efficient diabetes screening and monitoring in hospitals and laboratories.

Urinalysis – Comprehensive Metabolic Insights

Diabetes affects multiple organ systems, and urinalysis plays a key role in detecting kidney function abnormalities, infections, and glucose presence in urine. Arkray’s urinalysis systems provide highly detailed metabolic readings, allowing for early identification of renal complications that are common in long-term diabetes patients. With automated urine analyzers, the company supports hospitals and clinics in processing large volumes of samples with accuracy and speed.

Point-of-Care (POC) Diagnostics

Immediate decision-making in diabetes care depends on fast, reliable test results. Arkray’s POC diagnostic tools are designed for real-time glucose, ketone, and HbA1c testing in clinics, emergency settings, and outpatient care. These systems improve diagnostic efficiency, allowing physicians to adjust treatment plans without delays.

Why Arkray’s Solutions Matter

Diabetes affects over 37 million people in the US and 14 million in Mexico, according to the CDC and Mexican Ministry of Health. Accurate diagnostics and routine monitoring are essential to preventing complications like neuropathy, cardiovascular disease, and kidney failure. Arkray’s technology ensures that patients and healthcare professionals have the right tools to manage diabetes effectively, improving long-term outcomes through high-precision testing and real-time monitoring solutions.